Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Skillz in the transaction. Skillz (NYSE: SKLZ), the leading mobile games platform bringing fair and fun competition to players worldwide, has entered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters in the offering. Rain Therapeutics Inc. (Rain), a clinical-stage company developing precision oncology therapeutics, executed its initial public offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised Blend in the transaction, while Wachtell, Lipton, Rosen & Katz advised Mr. Cooper Group. Blend, a leader in digital lending software,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Okta, Inc. in the transaction while Perkins Coie LLP advised Auth0. Okta, Inc. (NASDAQ:OKTA), the leading independent identity provider, entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP acted as Hippo’s legal counsel, while Sullivan & Cromwell LLP served as Reinvent’s legal counsel for the transaction. Davis Polk advised the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised Owlet Baby Care, while Ropes & Gray LLP advised Sandbridge on the deal. Owlet Baby Care Inc. and Sandbridge Acquisition Corporation...
You must be a Standard 1 Year member to access this content.
